Cardiovascular disease is the leading cause of death in Manitoba. MindSet and Novartis Pharmaceuticals Canada Inc. are working together to learn more about uncontrolled cholesterol, the impact on Manitobans and their families, as well as the healthcare system as a whole. What does the data tell us? How can we use this information to reduce heart attacks and strokes in Manitoba?
Stay tuned for more updates!
For more information, please contact: